-
Good ED/ICU networks are becoming more important as more rural hospitals close due to lack of funding, says Janet Williams, MD, FACEP, director of the Center for Rural Emergency Medicine and Professor of Emergency Medicine at West Virginia University in Morgantown.
-
The randomized, controlled trial (RCT) is believed to provide the strongest evidence for verifying both effectiveness and ineffectiveness of a given treatment. Once the RCT judges the proposed treatment as ineffective, it is rare that the treatment is ever evaluated again.
-
Patients who were transferred directly to the authors medical ICU from other hospitals were sicker and had worse outcomes than those who were directly admitted. Benchmarking data generated without taking referral source into account erroneously indicated an excessive death rate and other adverse outcomes.
-
A time lapse of > 4 hours in ICU transfer after the development of 1 or more physiologic threshold criteria was associated with greater mortality, longer hospital length of stay, and higher costs.
-
Although noninvasive positive-pressure ventilation (NPPV) has become a standard of care for acute-on-chronic ventilatory failure in patients with chronic obstructive pulmonary disease (COPD), the numerous reported studies have left uncertain how the clinician should select patients who should receive this therapy.
-
The FDA has approved the first nasally administered flu vaccine to be marketed in this country. Medimmunes FluMist is also the first influenza vaccine to use live virus.
-
The Women's Health Initiatives was halted a year ago, but fallout
from this landmark study continues. The study was designed to identify
the risks or benefits of estrogen plus progesterone vs placebo in
healthy postmenopausal women.
-
This review will provide an overview of SARS for the primary care physician, including epidemiology, etiology, review of the clinical and laboratory features as well as diagnosis, therapy, and prevention of SARS.
-
Influenza Vaccination and Reduction in Hospitalizations; Screening Men
for Prostate and Colorectal Cancer; Weight Loss in CHF and Treatment
with ACE-I; Impaired Fasting Glucose vs Impaired Glucose Tolerance;
Risk Stratification in Long-QT Syndrome; EBCT, Motivation, Behavioral
Change, and Cardiovascular Risk Profile
-